Meeting Banner
Abstract #2571

Quantitative Measurement of Glymphatic Flow in Man with Contrast-Enhanced MRI

Christopher G Filippi1,2, Jared M Steinklein1,2, Leah E Waldman1,2, Xiangzhi Zhou1,2, George Pinder3, and Richard Watts4,5

1Radiology, Lenox Hill Hospital, New York, NY, United States, 2Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, United States, 3Department of Civil and Environmental Engineering, University of Vermont, Burlington, VT, United States, 4Department of Psychology, Yale University, New Haven, CT, United States, 5Department Radiology, University of Vermont, Burlington, VT, United States

Impairment in glial lymphatic "glymphatic" flow is hypothesized to be an etiologic factor in the development of Alzheimer’s disease (AD). We report a quantitative study of glymphatic flow in man, combining intrathecal administration of gadobutrol (macrocylic gadolinium-based contrast agent) with serial T1-mapping to produce contrast concentration maps up to 3 days post-injection. This demonstrates proof-of-concept feasibility and offers data on the pharmacokinetics of glymhatic flow.

This abstract and the presentation materials are available to members only; a login is required.

Join Here